Price $0.58 |
Market Cap
43.5M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
9.12
|
P/S
-
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-12.4K
|
FCF
-0.2
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-165.50%
|
ROI
-
|
|
ROA
-99.30%
|
EPS Growth
64.70%
|
Current Ratio
2.6
|
Debt/Equity
63.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Acura Pharmaceuticals, Inc. (ACUR) | $0.55 | - | - | 5.9M | Strong Buy |
| Hooper Holmes, Inc. (HPHW) | $0.72 | - | - | 17.8M | Strong Buy |
| Aralez Pharmaceuticals Inc (ARLZ) | $1.29 | - | - | 89.6M | Strong Buy |
| CRYO-CELL International, Inc. (CCEL) | $6.23 | - | - | 72.1M | Strong Buy |
| Enzon Pharmaceuticals Inc (ENZN) | $0.28 | - | - | 10.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
